Skip to content
healthcare.dev

Dicyclomine hydrochloride

NDC 16571-259, Dicyclomine hydrochloride, tablet, from Rising Pharma Holdings, Inc..

Product NDC
16571-259
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218952
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-259 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DICYCLOMINE HYDROCHLORIDE20 mg/1

Pharmacologic classes

Anticholinergic [EPC]; Cholinergic Antagonists [MoA]

Package NDCNDC-11Package
16571-259-0116571025901100 TABLET in 1 BOTTLE (16571-259-01)
16571-259-10165710259101000 TABLET in 1 BOTTLE (16571-259-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0a97e9c8-7046-4b92-93ad-dd9e01ce0fc4
  • NADAC price for package 16571025901

    GET /v1/drugs/nadac/16571025901
  • NADAC price for package 16571025910

    GET /v1/drugs/nadac/16571025910

Use it

Look up 16571-259 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-259 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-259. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.